Avantor Revenue 2018-2024 | AVTR

Avantor annual/quarterly revenue history and growth rate from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Avantor revenue for the quarter ending March 31, 2024 was $1.680B, a 5.65% decline year-over-year.
  • Avantor revenue for the twelve months ending March 31, 2024 was $6.867B, a 6.48% decline year-over-year.
  • Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
  • Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
  • Avantor annual revenue for 2021 was $7.386B, a 15.52% increase from 2020.
Avantor Annual Revenue
(Millions of US $)
2023 $6,967
2022 $7,512
2021 $7,386
2020 $6,394
2019 $6,040
2018 $5,864
2017 $1,247
Avantor Quarterly Revenue
(Millions of US $)
2024-03-31 $1,680
2023-12-31 $1,723
2023-09-30 $1,720
2023-06-30 $1,744
2023-03-31 $1,780
2022-12-31 $1,795
2022-09-30 $1,857
2022-06-30 $1,911
2022-03-31 $1,950
2021-12-31 $1,908
2021-09-30 $1,834
2021-06-30 $1,859
2021-03-31 $1,786
2020-12-31 $1,791
2020-09-30 $1,605
2020-06-30 $1,479
2020-03-31 $1,519
2019-12-31 $1,524
2019-09-30 $1,504
2019-06-30 $1,532
2019-03-31 $1,480
2018-12-31
2018-09-30 $1,494
2018-06-30 $1,478
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $15.025B $6.967B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.209B 15.59
Cencora (COR) United States $47.206B 18.40
ICON (ICLR) Ireland $26.298B 24.83
DiDi Global (DIDIY) China $21.580B 0.00
CochLear (CHEOY) Australia $14.104B 0.00
Revvity (RVTY) United States $13.324B 23.37
Natera (NTRA) United States $13.153B 0.00
Medpace Holdings (MEDP) United States $12.518B 41.19
Viatris (VTRS) United States $12.466B 3.73
EUROFINS SCIENT (ERFSF) Luxembourg $10.906B 0.00
Charles River Laboratories (CRL) United States $10.900B 20.87
Solventum (SOLV) United States $9.041B 0.00
Sonic Healthcare (SKHHY) Australia $8.666B 0.00
HealthEquity (HQY) United States $7.278B 46.73
Organon (OGN) United States $5.359B 5.08
Bausch + Lomb (BLCO) Canada $5.253B 21.03
Doximity (DOCS) United States $5.103B 35.74
PACS (PACS) United States $4.437B 0.00
Life Times (LTH) United States $3.659B 38.33
Sotera Health (SHC) United States $3.400B 16.68
Surgery Partners (SGRY) United States $3.113B 28.48
GoodRx Holdings (GDRX) United States $2.900B 110.43
Agilon Health (AGL) United States $2.681B 0.00
Progyny (PGNY) United States $2.462B 42.39
NovoCure (NVCR) Jersey $2.052B 0.00
AMN Healthcare Services Inc (AMN) United States $2.013B 7.98
Premier (PINC) United States $1.950B 8.34
BrightSpring Health Services (BTSG) United States $1.819B 0.00
Teladoc Health (TDOC) United States $1.647B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.388B 0.00
Establishment Labs Holdings (ESTA) $1.141B 0.00
CareDx (CDNA) United States $0.732B 0.00
Embecta (EMBC) United States $0.721B 4.91
GeneDx Holdings (WGS) United States $0.717B 0.00
Pediatrix Medical (MD) United States $0.673B 7.14
InnovAge Holding (INNV) United States $0.646B 0.00
Auna S.A (AUNA) Luxembourg $0.599B 0.00
Sharecare (SHCR) United States $0.497B 0.00
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
Enhabit (EHAB) United States $0.428B 42.70
COMPASS Pathways (CMPS) United Kingdom $0.427B 0.00
Sonida Senior Living (SNDA) United States $0.370B 0.00
ModivCare (MODV) United States $0.368B 6.88
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.289B 0.00
MultiPlan (MPLN) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Sera Prognostics (SERA) United States $0.217B 0.00
Biodesix (BDSX) United States $0.196B 0.00
Ascend Wellness Holdings (AAWH) United States $0.189B 0.00
So-Young (SY) China $0.108B 52.00
Pono Capital Two (PTWO) United States $0.068B 0.00
Co-Diagnostics (CODX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.042B 5.72
IceCure Medical (ICCM) Israel $0.034B 0.00
Oncology Institute (TOI) United States $0.033B 0.00
Nutex Health (NUTX) United States $0.028B 0.00
Singular Genomics Systems (OMIC) United States $0.026B 0.00
OncoCyte (OCX) United States $0.023B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.022B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00